Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis. Issue 1 (February 2018) - Masetti, C.; Lionetti, R.; Lupo, M.; Siciliano, M.; Giannelli, V.; Ponziani, F.R.; Teti, E.; Dell'Unto, C.; Francioso, S.; Brega, A.; Montalbano, M.; Visco-Comandini, U.; et al.